Download Unicorn Signals App

By EquityPandit

EquityPandit

EquityPandit
Latest News

Board Approves Fund Raising to Rs 18,000 crores: Axis Bank

Axis Bank looks forward to raising Rs 18,000 crore as board approves raising funds through issue of equity shares, convertible securities or depository receipts.
In a regulatory filing on Saturday, the private lender said that the Board of Directors of the bank approved the proposal in the same regard in the meeting.
The fund will be raised through issue of equity shares/depository receipts and/or any other instruments or securities representing either equity shares and/or convertible securities linked to equity shares including through Qualified Institutional Placement / American Depository Receipts/ Global Depository Receipts programme, preferential allotment or such other permissible mode or combinations as may be considered appropriate, said Axis Bank.
Read EquityPandit’s Nifty Bank Outlook for the Week
Since the Reserve Bank of India’s asset quality review, Axis Bank has been one of the worst affected private lenders which led to a huge increase in bad loans over the past three years.

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.
MARKETS

GR Infraprojects Shares Skyrocketed 14% on Bagging Rs 4,262 Crore Project 

Ali Waghbakriwala

Shares of GR Infraprojects Ltd skyrocketed 14% on 19 March after the company announced bagging a significant project worth Rs 4,262 crore from the NHAI for the Greenfield Route construction between Agra and Gwalior.

As part of the project, a six-lane, access-controlled greenfield highway connecting Madhya Pradesh, Rajasthan, and Uttar Pradesh would be built. Under the NH(O) plan, the current Agra-Gwalior sections in these states will also receive overlay/strengthening, road safety upgrades, and a DBFOT pattern improvement at BOT (Toll) Mode.

Earlier on 7 March, the company’s board of directors declared an interim dividend of Rs 12.50 per equity share, with a face value of Rs 5 per equity share, for the fiscal year 2024–2025. 

Furthermore, the plan to sell the company’s entire ownership stake or investment in GR Galgalia Bahadurganj Highway (GGBHPL) and transfer the company’s unsecured debt to GGBHPL was approved.

You Might Be Interested In

In February, the Assamese government signed a Memorandum of Understanding (MoU) with G R Infraprojects to create a ropeway from Sonaram Field to Bhubaneshwari temple, Kamakhya, near Guwahati. An estimated Rs 270 crore will be needed for the project.

The company said, “According to this MoU, the Government of Assam will facilitate GR Infraprojects Limited in the development of the ropeway by assisting in obtaining all necessary permissions, registrations, approvals, and clearances from the concerned departments, agencies, and authorities of the state, in accordance with the existing policies, rules, and regulations.”

At 12:35 pm, the shares of GR Infraprojects were trading 10.56% higher at Rs 1,040 on NSE.

Wondering About GR Infraprojects Ltd? The Analyst Has Answers.

Feeling overwhelmed by the markets? Let Unicorn Signals be your guide. Our user-friendly app simplifies complex data and provides actionable trading signals. Download the app today and trade with confidence!

MARKETS

Zydus Lifesciences Shares Surge 3% on Receiving Final USFDA Approval

Ali Waghbakriwala

Shares of Zydus Lifesciences Ltd surged 3% on 19 March after the company received final approval from the USFDA for Apalutamide Tablets, 60 mg.

The company, in its regulatory filing, announced that they have secured final approval from the US Food and Drug Administration (USFDA) to produce 60 mg Erleada Tablets (Apalutamide Tablets). Apalutamide is an androgen receptor inhibitor that may be useful in treating patients with metastatic castration-sensitive prostate cancer.  In its filing, the company added that these tablets will be produced at its Ahmedabad plant. 

Earlier on 16 March, the company received final approval from the USFDA to manufacture 75 mg and 100 mg Eluxadoline tablets. Eluxadoline, a mu-opioid receptor agonist, is administered to adults to treat IBS-D or irritable bowel syndrome with diarrhoea.

On 14 March, the company said that the USFDA had conducted an inspection visit at the group’s API Unit 1, located in Ankleshwar, Gujarat. The inspection, which took place between 10 March and 14 March 2025, concluded without any observations.

On 12  March, the USFDA granted the business final approval to manufacture Methenamine Hippurate Tablets USP, 1 gram, which are advised for the prevention or suppression of recurrent UTIs where long-term treatment is believed to be necessary.

Additionally, Zynext Ventures USA LLC, the company’s venture capital arm, revealed that it had invested in Illexcor Therapeutics (Illexcor), a cutting-edge biopharmaceutical business creating next-generation oral medications for sickle cell disease (SCD).

At 11:33 am, the shares of Zydus Lifesciences were trading 1.04% higher at Rs 911.60 on NSE. 

Curious About Zydus Lifesciences Ltd? Ask the Analyst.

Discover the next big investment! Unicorn Signals’ IPO screener helps you identify promising initial public offerings. Download Unicorn Signals and get ahead of the curve! Sign Up Now & Find Your Next IPO Gem!

MARKETS

Stocks Under F&O Ban: Steel Authority of India, BSE Ltd, and Others

Ali Waghbakriwala

Under the futures and options (F&O) segment, five stocks were banned from trade on Wednesday, 19 March, by the National Stock Exchange (NSE). The securities banned for the F&O trade are BSE Limited, Manappuram Finance, Hindustan Copper, IndusInd Bank, and Steel Authority of India.  

Derivative contracts of these stocks were banned as the open market interest for these securities has crossed 95% of the market-wide position limit (MWPL) set by the exchanges. The MWPL is the maximum number of contracts that can be opened at any particular time.

BSE Ltd, Manappuram Finance, and Hindustan Copper were retained on the list from Monday as the open interest as a percentage of the MWPL of its F&O contracts stood at 82.2%, 81%, and 91.3%, respectively. 

IndusInd Bank derivative contracts’ open interest was 106.6% of its MWPL on 19 March, compared to 89.8% for Steel Authority of India. 

The ban will be lifted once the position falls below 80%. Traders will get penalised for buying or selling these securities. They will be available for trading in the cash market. 

The National Stock Exchange updates the list of securities on the F&O ban list daily. This list serves as a guide for traders and investors in the market. Traders who trade in indices do not encounter a situation of security ban.

Ready to invest like a pro? Unicorn Signals app equips you with 100+ Free tools and knowledge you need to succeed. Download the Unicorn Signals app and gain access to daily stock lists and insightful market analysis and much more!

MARKETS

Stocks in Focus: GR Infraprojects, Zydus Lifesciences, Zen Tech, and Others

Ali Waghbakriwala

The GIFT Nifty futures, which is an early indicator of the Nifty50 index, was trading 0.12% higher by 26 points at 22,957, indicating that the domestic benchmark indices are likely to make a positive start on Wednesday.

On Tuesday, 18 March, Domestic benchmark indices S&P BSE Sensex skyrocketed by 1,131.30 points or 1.53% and settled at 75,301.26 while the Nifty50 traded 1.45% higher by 325.55 points, settling at 22,834.30.

Here are some stocks that are likely to remain in focus on 19 March.

GR Infraprojects: The company has announced securing a major contract worth Rs 4,262.78 crore from the National Highway Authority of India. The scope of the project is to build and improve the Agra-Gwalior road, spanning across Uttar Pradesh, Rajasthan, and Madhya Pradesh.

Zydus Lifesciences: The company announced securing approval from the US Food and Drug Administration (USFDA) to manufacture and market apalutamide tablets, which are used to treat metastatic castration-sensitive prostate cancer.

Zen Technologies: The company has announced acquiring a 54.33% stake in Bhairav Robotics, making it an associate company. 

BPCL: The company has announced signing a quadripartite Memorandum of Understanding (MoU) with the Agency for New and Renewable Energy Research and Technology, Cochin International Airport, BluJ Aerospace, and the Government of Kerala for developing the first hydrogen-fueled Vertical Take-off and Landing aircraft ecosystem globally. 

Larsen and Toubro: The Board of Directors of the company are set to meet on 21 March to consider and approve a potential fundraising via debt issue.

Vodafone Idea: The company has announced the launch of the 5G network in Mumbai and has also announced its plans to roll out in Bengaluru, Patna, Delhi, Chandigarh, and Mysuru by the end of April 2025.

Nazara Tech: The company has announced that it will acquire 18,330 equity shares or 8.97% of Absolute Private Limited from eligible employees for a total consideration of Rs 69.17 crore. This acquisition took the company’s share in Absolute from 91.03% to 100%, making it a wholly owned subsidiary of the company.

Tired of guessing stocks to trade in daily?
Unicorn Signals empowers you with powerful tools like daily stock scans for Intraday, Swing & Investing, Market Predictions and much more. Download the Unicorn Signals app today and take control of your investments!

MARKETS

Hypergro.ai Secures Rs 7 Crore Funding in Series A Round 

Ali Waghbakriwala

Hypergro.ai, an AI-powered platform for creating and converting videos, has raised Rs 7 crore in a pre-Series A investment round led by Eternal Capital. 

VCats, Astir Ventures, Silver Needle Ventures, and FAAD Network were among the notable investors who took part in the round.

The company claims that the investment would strengthen its position as a leader in AI-driven marketing automation and accelerate its global expansion and innovation.

Hypergro.ai was formed in 2022 by Rituraj Biswas and Neha Soman to address the fundamental inefficiencies of digital marketing, including fragmented data, manual execution, and a lack of real-time knowledge.

The startup’s AI-powered platform, which optimises performance campaigns, engages leads with AI-powered sales agents, and automates video creation, enables brands to execute marketing strategies at a never-before-seen scale.

Rituraj Biswas, Co-founder & CEO of Hypergro.ai, said, “At Hypergro.ai, we combine AI-driven content generation, real-time campaign optimisation, and automated lead engagement into a single intelligent system. This ensures brands drive maximum revenue impact with minimal effort.”

The Bengaluru-based company claims to have created videos 92% faster and at 80% less expense than traditional methods.  Additionally, because businesses are large, it offers AI-automated video personalisation, aspect ratio, and format adjustments, satisfying their demands for multi-platform video optimisation and custom video content tailored to specific audiences and regions.

At the time of this funding, companies are rapidly deploying AI-driven automation to increase revenue.  In addition to quickly penetrating foreign markets like the U.S., APAC, and GCC, Hypergro.ai said it is investing in AI R&D, strategic hiring, and enterprise relationships.

Hypergro.ai intends to raise money in a Series A financing round in the next six to eight months in order to further incorporate AI into enterprise ad-tech solutions. The company hopes to rule the worldwide AI marketing ERP market by 2027.

To support brands in e-commerce, retail, entertainment, gaming, travel, and hospitality, it currently collaborates with companies like ClearTrip, Newton School, Gameskraft, and Docube, among others.

Ready to invest like a pro? Unicorn Signals app equips you with 100+ Free tools and knowledge you need to succeed. Download the Unicorn Signals app and gain access to daily stock lists and insightful market analysis and much more!

@2025 - www.equitypandit.com. All Right Reserved.
Latest
IPO
Weekly
Outlook

Stock
Market
Prediction